Z-0282-2021 Class II Terminated

Recalled by Fujifilm Medical Systems U.S.A., Inc. — Lexington, MA

FDA device recall Z-0282-2021 was initiated by Fujifilm Medical Systems U.S.A., Inc. on Sep 11, 2020 and is designated Class II. Reason for recall: FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not… The recall status is terminated (terminated Nov 17, 2021). Affected quantity: 1.

Recall details

Product Type
Devices
Report Date
Oct 28, 2020
Initiation Date
Sep 11, 2020
Termination Date
Nov 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product description

Synapse PACS Software Version 5.6.1 - Product Usage: intended for use as a web based application on an off-the shelf PC which meets or exceeds minimum specifications and is networked with a FUJIFILM Synapse PACS server.

Reason for recall

FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not affected.

Distribution pattern

US Nationwide distribution including in the state of Minnesota.

Code information

Synapse Software Version 5.6.1

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0282-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0282-2021. Report a data issue: hello@regdatalab.com.